Publications by authors named "R Mattison"

Claim this Profile
E
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).
Robert Jeraj, Fenghai Duan, Ryan J Mattison, Justin Romanoff, Lale Kostakoglu

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.
Mikkael A Sekeres, Ryan J Mattison, Andrew S Artz, Maria R Baer, Chong Chyn Chua

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.
Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude, Deepa Bhojwani, Alan S Wayne, Ryan J Mattison

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.
Athalia R Pyzer, Laura W Dillon, Elad Sharon, Theodore G Karrison, Yuanyuan Zha, Ryan J Mattison

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Julie E Chang, Danielle McQuinn, Meredith Hyun, KyungMann Kim, Vaishalee P Kenkre, Ryan J Mattison

Clin Lymphoma Myeloma Leuk· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis